150 related articles for article (PubMed ID: 29199659)
21. Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas.
Levy A; Blanchard P; Bellefqih S; Brahimi N; Guigay J; Janot F; Temam S; Daly-Schveitzer N; Bourhis J; Tao Y
Anticancer Drugs; 2014 Nov; 25(10):1220-6. PubMed ID: 25144345
[TBL] [Abstract][Full Text] [Related]
22. Multidisciplinary approach in advanced cancer of the oral cavity: outcome with neoadjuvant chemotherapy according to intention-to-treat local therapy. A phase II study.
Grau JJ; Domingo J; Blanch JL; Verger E; Castro V; Nadal A; Alós L; Estapé J
Oncology; 2002; 63(4):338-45. PubMed ID: 12417788
[TBL] [Abstract][Full Text] [Related]
23. Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324.
Sher DJ; Posner MR; Tishler RB; Sarlis NJ; Haddad RI; Holupka EJ; Devlin PM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e813-8. PubMed ID: 21300455
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
[TBL] [Abstract][Full Text] [Related]
25. Surgical site infection after preoperative neoadjuvant chemotherapy in patients with locally advanced oral squamous cell carcinoma.
Liu SA; Wong YK; Wang CP; Wang CC; Jiang RS; Ho HC; Lin JC
Head Neck; 2011 Jul; 33(7):954-8. PubMed ID: 21674671
[TBL] [Abstract][Full Text] [Related]
26. A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141.
Kiyota N; Hasegawa Y; Takahashi S; Yokota T; Yen CJ; Iwae S; Shimizu Y; Hong RL; Goto M; Kang JH; Sum Kenneth Li W; Ferris RL; Gillison M; Namba Y; Monga M; Lynch M; Tahara M
Oral Oncol; 2017 Oct; 73():138-146. PubMed ID: 28939066
[TBL] [Abstract][Full Text] [Related]
27. Induction chemotherapy with the EXTREME regimen in frail patients with locally advanced head and neck squamous cell carcinoma.
Cochin V; de Mones E; Digue L; Garcia-Ramirez M; Dupin C; Majoufre C; Fernandez P; Daste A
Target Oncol; 2018 Apr; 13(2):247-252. PubMed ID: 29404898
[TBL] [Abstract][Full Text] [Related]
28. [Clinical analysis of multimodal treatment for orbital organ preservation in T4b squamous cell carcinoma of nasal cavity and paranasal sinuses].
Chen NX; Zhang XX; Chen L; Wang JL; Yan F; Ma L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jul; 51(7):497-503. PubMed ID: 27480297
[TBL] [Abstract][Full Text] [Related]
29. A phase I study of cabazitaxel in combination with platinum and 5-fluorouracil (PF) in locally advanced squamous cell carcinoma of head and neck (LA-SCCHN).
Camille N; Rozehnal J; Roy E; Uczkowski D; Olson A; Genden E; Teng M; Bakst R; Gupta V; Posner M; Misiukiewicz K
Oral Oncol; 2017 Aug; 71():99-104. PubMed ID: 28688700
[TBL] [Abstract][Full Text] [Related]
30. Prognostic determinants of locally advanced buccal mucosa cancer: Do we need to relook the current staging criteria?
Pillai V; Yadav V; Kekatpure V; Trivedi N; Chandrashekar NH; Shetty V; Rangappa V; Subramaniam N; Bhat V; Raghavan N; Kolur T; George N; Thomas T; Kuriakose MA
Oral Oncol; 2019 Aug; 95():43-51. PubMed ID: 31345393
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant chemotherapy in early-stage and locally advanced small bulk squamous cell carcinoma of the oral cavity and oropharynx.
Tichler T; Ramon Y; Rath P; Hendler S; Brenner HJ
Isr J Med Sci; 1988; 24(9-10):539-44. PubMed ID: 2462551
[TBL] [Abstract][Full Text] [Related]
32. A clinical study of multimodal treatment for orbital organ preservation in locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus.
Chen NX; Chen L; Wang JL; Wang JY; Yan F; Ma L; Zhang XX
Jpn J Clin Oncol; 2016 Aug; 46(8):727-34. PubMed ID: 27207888
[TBL] [Abstract][Full Text] [Related]
33. Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysis.
Elicin O; Schmucking M; Bromme J; Rauch D; Ambarcioglu P; Plasswilm L; Geretschlager A; Ghadjar P; Giger R; Aebersold DM
J BUON; 2016; 21(1):175-81. PubMed ID: 27061546
[TBL] [Abstract][Full Text] [Related]
34. Induction chemotherapy before surgery for unresectable head and neck cancer.
Schmaltz H; Borel C; Ciftci S; Takeda-Raguin C; Debry C; Schultz P; Dupret-Bories A
B-ENT; 2016; 12(1):29-32. PubMed ID: 27097391
[TBL] [Abstract][Full Text] [Related]
35. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.
Gandhi AK; Roy S; Biswas A; Raza MW; Saxena T; Bhasker S; Sharma A; Thakar A; Mohanti BK
Auris Nasus Larynx; 2016 Feb; 43(1):45-9. PubMed ID: 26165629
[TBL] [Abstract][Full Text] [Related]
36. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.
Yokota T; Onozawa Y; Boku N; Hamauchi S; Tsushima T; Taniguchi H; Todaka A; Machida N; Yamazaki K; Fukutomi A; Yasui H
Jpn J Clin Oncol; 2011 Dec; 41(12):1351-7. PubMed ID: 21980053
[TBL] [Abstract][Full Text] [Related]
37. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
Budach W; Bölke E; Kammers K; Gerber PA; Orth K; Gripp S; Matuschek C
Radiother Oncol; 2016 Feb; 118(2):238-43. PubMed ID: 26589131
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS
Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372
[TBL] [Abstract][Full Text] [Related]
39. nab-Paclitaxel-based induction chemotherapy with or without cetuximab for locally advanced head and neck squamous cell carcinoma.
Adkins D; Ley J; Oppelt P; Wildes TM; Gay HA; Daly M; Rich J; Paniello RC; Jackson R; Pipkorn P; Nussenbaum B; Trinkaus K; Thorstad W
Oral Oncol; 2017 Sep; 72():26-31. PubMed ID: 28797458
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
